Skip to main content
. 2021 Oct 7;196(3):566–576. doi: 10.1111/bjh.17870

Table III .

Impact of major bleeding and thrombosis on mortality following initiation of VV ECMO.

Complication n = (152) Alive (n = 107) Dead (n = 45) Crude time‐adjusted HR (95% CI) Time‐adjusted HR* (95% CI)
Major bleeding 47 (30·9%) 23 (48·9%) 24 (51·1%) 3·01 (1·63–5·51) 3·87 (2·10–7·23)
ICH 16 (34%) 6 (37·5%) 10 (62·5%) 3·30 (1·36–7·76) 5·97 (2·36–15·04)
GI 5 (11%) 2 (40%) 3 (60%)
Other 3 (6%) 2 (66%) 1 (33%)
Pulmonary haemorrhage 12 (26%) 5 (41·7%) 7 (58·3%)
>1 Bleeding site 11 (23%) 8 (72·7%) 3 (27·3%)
Venous thrombosis 68 (44·7%) 48 (70·6%) 20 (29·4%) 1·14 (0·61–2·14) 1·63 (0·94–3·04)
PE 45 (66·2%) 28 (26·2%) 17 (37·8%) 2·12 (1·19–3·76) 2·00 (1·09–3·56)
DVT 13 (19·1%) 11 (84·6%) 2 (15·4%)
PE and DVT 10 (14·7%) 9 (90%) 1 (10%)
Arterial thrombosis 13 (8·6%) 6 (46·2%) 7 (53·8%) 1·74 (1·24–6·14) 1·70 (0·71–3·92)
ECMO circuit thrombosis 15 (9·9%) 12 (80·0%) 3 (20·0%) 0·92 (0·26–3·04) 0·79 (0·34–2·78)

CI, confidence interval; DVT, deep vein thrombosis; GI, gastrointestinal; HR, hazard ratio; ICH, intracranial haemorrhage; PE, pulmonary embolism; VV ECMO, veno‐venous extracorporeal membrane oxygenation.

Numbers in bold type indicate complications that are associated with increased risk of mortality.

*

Adjusted for patient age and duration of mechanical ventilation. All HRs are shown relative to not having the condition of interest (HR 1·00).